Can anyone suggest why the FDA are being so slow in their response regards the p3 trials. It always appeared that it would be a clear cut decision to give the go ahead and yet here they are taking a long time to make a decision , given PAR has fast track designation.
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.070(23.0%) |
Mkt cap ! $146.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 41.0¢ | 33.0¢ | $1.677M | 4.466M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 118804 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 50516 | 3 |
View Market Depth
| Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |